Home/Filings/4/0001209191-19-033137
4//SEC Filing

Driscoll Martin J 4

Accession 0001209191-19-033137

CIK 0001566373other

Filed

May 28, 8:00 PM ET

Accepted

May 29, 11:22 AM ET

Size

4.6 KB

Accession

0001209191-19-033137

Insider Transaction Report

Form 4
Period: 2019-05-29
Driscoll Martin J
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2019-05-29$6.03/sh+10,000$60,30085,400 total

Issuer

Spring Bank Pharmaceuticals, Inc.

CIK 0001566373

Entity typeother

Related Parties

1
  • filerCIK 0001339402

Filing Metadata

Form type
4
Filed
May 28, 8:00 PM ET
Accepted
May 29, 11:22 AM ET
Size
4.6 KB